Medication & Safety
How Much Does Ozempic Cost? A Country-by-Country Guide
Ozempic costs $800–$1000 per month in the US without insurance. Costs vary widely globally. Here is the complete breakdo...
Ozempic (semaglutide) is not recommended during pregnancy. This is a firm, consistent recommendation from every major regulatory body and medical association that has reviewed the evidence. If you are pregnant, planning to become pregnant, or discover a pregnancy while on semaglutide, this is among the most important things to discuss with your physician immediately.
This article explains what the evidence shows, why the recommendation exists, and what to do in different scenarios.
What the Evidence Shows
There are no adequate, well-controlled clinical studies of semaglutide in pregnant humans. This is standard practice — pregnant women are excluded from most drug trials for safety reasons.
The available evidence comes from animal reproductive toxicity studies. In animal studies, semaglutide produced adverse effects on embryo-foetal development, including:
- Increased rates of structural malformations
- Growth restriction in foetuses
- Effects at doses relevant to human exposure levels
Because of these animal findings and the absence of human safety data, both Novo Nordisk and regulatory agencies (FDA, EMA, DRAP equivalents) classify semaglutide as Category X equivalent — meaning the potential risks during pregnancy outweigh potential benefits, and it should not be used.
Why the Risk Exists
GLP-1 receptors are present in placental tissue and in developing foetal organs. Animal studies suggest interference with normal foetal GLP-1 signalling during key developmental windows can produce structural and growth abnormalities. Whether this applies at human doses is not known from human data, but the precautionary principle — standard in pregnancy medicine — applies clearly here.
Additionally, weight loss itself during pregnancy carries risks to the foetus. Calorie restriction and significant weight loss during pregnancy are associated with growth restriction and other adverse outcomes. The appetite-suppressing mechanism of semaglutide would produce calorie restriction in a pregnant woman.
What to Do If You Discover a Pregnancy on Semaglutide
Stop semaglutide immediately and contact your physician and obstetrician the same day. Do not wait for your next scheduled appointment.
Because semaglutide has a long half-life of approximately one week, it takes several weeks to fully clear the body after the last dose. The significance of early pregnancy exposure is not clearly established, but your obstetrician will want to know the timing, duration, and dose of exposure to inform appropriate monitoring.
Do not be alarmed — many pregnancies in women who were unknowingly on semaglutide early on have progressed normally. The concern is sufficient that monitoring is appropriate; it does not mean harm is guaranteed.
What If I Want to Become Pregnant?
Stop semaglutide at least two months before attempting to conceive. This recommendation accounts for the long half-life and allows time for the drug to fully clear before conception.
Some physicians recommend a longer washout period of four to eight weeks beyond the two-month minimum for additional safety margin. Discuss the specific timeline with your physician based on your dose and treatment duration.
Note that effective weight management achieved before pregnancy may actually reduce obstetric risk. Women with obesity face elevated risks during pregnancy — gestational diabetes, hypertension, and complications. Achieving a healthier weight before conception through a supervised program, then discontinuing semaglutide and maintaining that weight, is a reasonable approach.
Alternative Weight Management During Pregnancy
If you are pregnant and need support with weight management, standard recommendations apply: physician-guided nutrition counselling, appropriate gestational weight gain guidance based on pre-pregnancy BMI, and exercise appropriate to pregnancy stage.
For women who used METASLIM's physician-guided program and then became pregnant: the same precautionary approach applies. Any GLP-1 pathway supplementation should be stopped before attempting to conceive and must not be used during pregnancy.